Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 30,629 followers.

RT @NCIKerlavage: Interesting #glioblastoma treatment response and survival study coming from @theNCI’s Daoud Meerzaman and other #CancerRe…

#NCICBIIT’s Dr. Daoud Meerzaman worked with a panel to explore proteomic alterations and classify #glioblastoma by integrating clinical and proteomic parameters. Learn more about this research: https://t.co/AKpO08ZF7l https://t.co/rHBxB7SS7T

More great work coming from my @theNCI colleague, Daoud Meerzaman!

Interesting #glioblastoma treatment response and survival study coming from @theNCI’s Daoud Meerzaman and other #CancerReserach community members: https://t.co/n0x3WLsgzb https://t.co/jQY2fCVFaF

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.